Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Calcific aortic valve disease (CAVD) is a highly prevalent, disabling and costly disorder with generally poor long-time outcomes once critical stenosis presents with symptoms. Elucidating viable therapeutic strategies for CAVD is pressing. Valvular interstitial cells (VICs) control the structure and function of aortic valve. Intra-leaflet haemorrhage (IH), commonly occurring in histologically stenotic aortic valves, while, in 2019, researchers pointed that iron deposits also presented obviously healthy valves. In line with this, later exploration from vitro showed that iron stimulation alone could not promote VICs calcification. Iron deficiency (ID) is a frequent co-morbidity in multiple chronic cardiovascular diseases such as CAVD; up to 50% of patients with severe aortic stenosis present ID. Data from a small clinical study in patients undergoing TAVI showed those in ID status appeared much higher mean transaortic gradient; whereas no studies have assessed the correlation between ID and aortic valve remodelling and dysfunction progress itself. Here, the investigators aim to investigate for a tentative correlation between ID and human aortic valve remodeling and dysfunction.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| aortic valvular sclerosis group | |||
| non-aortic valvular sclerosis group |
Not provided
| Measure | Description | Time Frame |
|---|---|---|
| Serum iron | Plasma levels of serum iron will be reported in μmol/L. | within 24 hours of admission |
| Total iron binding capacity | Total iron binding capacity will be reported in μmol/L. | within 24 hours of admission |
| Serum transferrin receptor | Plasma levels of serum transferrin receptor will be reported in g/L. | within 24 hours of admission |
| Unsaturated iron-binding capacity | Serum iron and total iron binding capacity will be combined to report unsaturated iron-binding capacity in μmol/L. | within 24 hours of admission |
| Serum transferrin | Plasma levels of serum transferrin will be reported in g/L. | within 24 hours of admission |
| Transferrin saturation | Serum iron and total iron binding capacity will be combined to report transferrin saturation in %. | within 24 hours of admission |
| Soluble transferrin index | Serum iron and serum transferrin will be combined to report soluble transferrin index. | within 24 hours of admission |
Not provided
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Patients at the outpatient clinic or inpatient department, Qilu hospital of Shandong University, Jinan, were recruited during the period from January 2018 to March 2023.
Limited by the submitted ethical protocols
Not provided
Not provided
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000090463 | Iron Deficiencies |
| C562942 | Aortic Valve, Calcification of |
| ID | Term |
|---|---|
| D019189 | Iron Metabolism Disorders |
| D008659 | Metabolic Diseases |
| D009750 | Nutritional and Metabolic Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided